Health-Related Quality of Life and Functional Status of Post-COVID-19 Patients
How to cite: Oliveira, M.; Alves, L.; Soares, J.; Souza, S.; Fonseca, A.; Silva, C.; Oliveira, C.; Vieira, R.; Oliveira, D.; Oliveira-Silva, I.; Oliveira, R.; Sampaio, L.; Maldaner, V.; Santos, D.; Palma, R.; Nacif, S.; Insalaco, G.; Oliveira, L.; Silva, B. Health-Related Quality of Life and Functional Status of Post-COVID-19 Patients. Preprints 2024, 2024102479. https://doi.org/10.20944/preprints202410.2479.v1 Oliveira, M.; Alves, L.; Soares, J.; Souza, S.; Fonseca, A.; Silva, C.; Oliveira, C.; Vieira, R.; Oliveira, D.; Oliveira-Silva, I.; Oliveira, R.; Sampaio, L.; Maldaner, V.; Santos, D.; Palma, R.; Nacif, S.; Insalaco, G.; Oliveira, L.; Silva, B. Health-Related Quality of Life and Functional Status of Post-COVID-19 Patients. Preprints 2024, 2024102479. https://doi.org/10.20944/preprints202410.2479.v1
Abstract
Background: COVID-19 mainly affects the respiratory system, although its manifestations are multisystemic. Increasingly, complications presented after the acute phase are still being rec-ognized and are associated with impaired functional status and health-related quality of life (HRQoL). The objective was assess the functional status and HRQoL of patients with post-COVID-19. Methods: This was a cross-sectional study involving individuals affected by COVID-19 who had persistent symptoms for one month after the acute phase of the disease. HRQoL was verified through the Short Form Health Survey 36 (SF-36) and, functional status was assessed using the six-minute walk test (6MWT), the Fatigue Severity Scale (FSS), the Med-ical Research Council (MRC) Dyspnea Scale and, the Post-COVID-19 Functional Status Scale (PCFS). Results: Were included 123 patients, 73 (59.35%) were male, with a mean age of 49.17±13.48 years and a body mass index of 31.02±6.56 stratified into three groups, not recov-ered group (NRG=23), ward recovered group (WHG=60), and intensive care unit group (ICUG=40). The main symptoms were muscle weakness (74.17%) and dyspnea (68.33%). In rela-tion to the distance covered in the 6MWT, the GNR group walked 12.83% below the predicted values, GNR 20.21% and the UGCI 28.82%, respectively. The MRC dyspnea scale had a mean value of less than 3 and the FSS scale had a mean value over 4, indicating considerable fatigue. In the PCFS scale, a significant difference was observed (p>0.0005); while in the SF-36, all HRQoL domains were compromised. Conclusion: Post-COVID-19 patients involved in this study showed a significant decline in functional status and an impairment of HRQoL.
Keywords
COVID-19; functional status; health-related quality of life
Subject
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
